Bladder cancer: open trials in Romania

• 2026-526359-75-00

  A Rollover Study to Follow the Long-term Durability of Response to UGN-103 in Participants With Recurrent Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer (LG-IR-NMIBC) From Study BL013

  Trial Treatment · Phase 4 · Urogen Pharma Ltd.

  Spitalul Clinic Judetean de Urgenta Brasov, Brasov · Spitalul Clinic Colentina Bucuresti, Bucharest

  Registry updated 2026-09-15

• NCT05303532

  Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab

  Trial Treatment · Phase 3 · Astrazeneca AB

  Sigmedical Services S.R.L., Suceava

  Registry updated 2026-09-08

• NCT06774131

  A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

  Trial Treatment · Phase 3 · UroGen Pharma Ltd.

  Delta Health Care S.R.L, Bucharest · "Dr. Carol Davila" Nephrology Clinical Hospital Bucharest, Bucharest · Municipal Clinical Hospital Cluj-Napoca, Cluj-Napoca · Regional Institute of Oncology Iasi, Iași · Bihor County Emergency Clinical Hospital, Oradea · Timisoara County Clinical Emergency Hospital Pius Brinzeu, Timișoara

  Registry updated 2026-09-03

• NCT07106762

  Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  Trial Treatment · Phase 2/3 · Bristol-Myers Squibb

  Institutul Oncologic Cluj, Cluj-Napoca · Centrul de Oncologie "Sfântul Nectarie", Craiova · Institutul Regional de Oncologie, Iași

  Registry updated 2026-07-29

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error